Wouter Goutier

Synthesis and SAR of novel imidazoles as potent and selective cannabinoid CB2 receptor antagonists with high binding efficiencies

Jos H.M. Lange, Martina A.W. van der Neut, Henri C. Wals et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 27 citations · Full text

Cannabis Use, Medicinal Chemistry, Drug Target +11

Development and application of an LC–MS/MS method for measuring the effect of (partial) agonists on cAMP accumulation in vitro

Wouter Goutier, P.A. Spaans, Martina A.W. van der Neut et al. · Journal of Neuroscience Methods · 2010 · 25 citations

Molecular Pharmacology, Pharmacokinetic Modeling, Preclinical Drug Evaluation +11

The effect of nicotine induced behavioral sensitization on dopamine D1 receptor pharmacology: An in vivo and ex vivo study in the rat

Wouter Goutier, John O’Connor, John Lowry et al. · European Neuropsychopharmacology · 2015 · 15 citations

Psychoactive Drug, Behavioral Neuroscience, Addiction +13

The effect of varenicline on the development and expression of nicotine‐induced behavioral sensitization and cross‐sensitization in rats

Wouter Goutier, Margreet B. Kloeze, Andrew C. McCreary · Addiction Biology · 2013 · 14 citations · Full text

Psychopharmacology, Locomotor Activity, Pharmacotherapy +16

WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: A Novel Dopamine D2 Receptor Partial Agonist/Serotonin Reuptake Inhibitor with Preclinical Antipsychotic-Like and Antidepressant-Like Activity

Julie Brennan, Radka Graf, Steven M. Grauer et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 14 citations